RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan 7, 2014--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 prior to its investor call on Thursday, February 13, 2014, at 8 a.m. EST to discuss fourth quarter financial results and to provide 2014 financial guidance.
The conference call will be accessible, live via webcast, through the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.
An archived edition of the conference call will be available online at www.quintiles.com/investors after 1?p.m. EST on Thursday, February 13th.
Quintiles (NYSE: Q) is the world's largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Click here to subscribe to Mobile Alerts for Quintiles.
Phil Bridges, + 1-919-998-1653
Karl Deonanan, +1-919-998-2789
KEYWORD: UNITED STATES NORTH AMERICA CANADA NORTH CAROLINA
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
Copyright Business Wire 2014
PUB: 01/07/2014 08:30 AM/DISC: 01/07/2014 08:30 AM